Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ho

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Medicine|October 3, 2019
Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcomeMan Hu, Peng Xie, Nancy Y Lee, et al.
Nature Communications|October 7, 2021
The GPR171 pathway suppresses T cell activation and limits antitumor immunityYuki Fujiwara, Robert J Torphy, Yi Sun, et al.
Oral Oncology|May 12, 2015
Definitive chemoradiation for primary oral cavity carcinoma: A single institution experienceEli D Scher, Paul B Romesser, Christine Chen, et al.
Nature Communications|January 11, 2022
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma modelsRobert J Torphy, Yi Sun, Ronggui Lin, et al.
Annals of Surgical Oncology|September 19, 2021
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node DissectionRobert J Torphy, Chloe Friedman, Felix Ho, et al.
Annals of Surgical Oncology|April 22, 2021
Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction AdenocarcinomaFelix Ho, Robert J Torphy, Chloe Friedman, et al.
Head & Neck|June 24, 2014
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancersBenjamin H Lok, Christine Chin, Nadeem Riaz, et al.
Photosynthesis Research|April 22, 2025
Probing substrate water access through the O1 channel of Photosystem II by single site mutations and membrane inlet mass spectrometryA Orkun Aydin, Casper de Lichtenberg, Feiyan Liang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Medicine|October 3, 2019
Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcomeMan Hu, Peng Xie, Nancy Y Lee, et al.
Nature Communications|October 7, 2021
The GPR171 pathway suppresses T cell activation and limits antitumor immunityYuki Fujiwara, Robert J Torphy, Yi Sun, et al.
Oral Oncology|May 12, 2015
Definitive chemoradiation for primary oral cavity carcinoma: A single institution experienceEli D Scher, Paul B Romesser, Christine Chen, et al.
Nature Communications|January 11, 2022
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma modelsRobert J Torphy, Yi Sun, Ronggui Lin, et al.
Annals of Surgical Oncology|September 19, 2021
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node DissectionRobert J Torphy, Chloe Friedman, Felix Ho, et al.
Annals of Surgical Oncology|April 22, 2021
Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction AdenocarcinomaFelix Ho, Robert J Torphy, Chloe Friedman, et al.
Head & Neck|June 24, 2014
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancersBenjamin H Lok, Christine Chin, Nadeem Riaz, et al.
Photosynthesis Research|April 22, 2025
Probing substrate water access through the O1 channel of Photosystem II by single site mutations and membrane inlet mass spectrometryA Orkun Aydin, Casper de Lichtenberg, Feiyan Liang, et al.
Pageof 2